Latest debt-to-equity ratio
Crescent Biopharma Debt-to-equity ratio
Direct answer
Crescent Biopharma's debt-to-equity ratio is 0.88%.
The verified market snapshot reports 0.88%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 1, 2026.
Get free Crescent Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.88%